Understanding how environmental factors affect genetic traits in diverse populations

APOL1 as a model to quantify and identify environmental modifiers of genetic associations in diverse populations

NIH-funded research Case Western Reserve University · NIH-10983483

This study is looking at how things in our environment, like where we live and our social conditions, can affect the way a specific gene related to kidney disease works, especially in African Americans, to help find better ways to prevent and treat kidney issues.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-10983483 on NIH RePORTER

What this research studies

This research investigates how environmental factors can modify the effects of genetic traits, specifically focusing on the APOL1 gene, which is linked to kidney disease in African American populations. By analyzing large datasets that include diverse populations, the study aims to identify social and environmental determinants that influence health outcomes. Patients may benefit from insights that could lead to targeted prevention and treatment strategies based on their genetic and environmental backgrounds.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals of African descent, particularly those with a family history of kidney disease or related health disparities.

Not a fit: Patients who do not have African ancestry or those without any genetic predisposition to kidney disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for kidney disease in populations affected by the APOL1 gene.

How similar studies have performed: Previous research has shown success in identifying genetic and environmental interactions in health outcomes, making this approach promising yet still relatively novel in its specific focus on the APOL1 gene.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.